Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...

On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...

The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...

Commerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and ...

Amneal Pharmaceuticals has sued Colorado in an effort to block a state law requiring it to provide free generic EpiPens to ...

Union Commerce Minister Piyush Goyal has invited American companies to leverage India’s unmatched scale and take advantage of ...

Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a prominent player in the specialty pharmaceuticals sector, has been making waves in the market with its recent performance and strategic initiatives.

Discover Amneal Pharmaceuticals' innovative patent for a controlled release levodopa formulation, enhancing drug delivery without decarboxylase inhibitors.

The commerce minister invited US businesses to join India’s growth journey, fostering stronger bilateral ties and driving ...

Delilah Alvarado Obesity drug startup Metsera said Tuesday it has signed a deal with manufacturing firm Amneal ...